Obstetrics/Gynecology Topics
RSSArticles
-
Data Suggest Abortion Does Not Lead to Depression
Results of a new study of almost 400,000 women indicate that having an abortion does not increase the risk for depression in women. The publication comes at a time when many state policies restricting abortion access have been justified by claims that abortion causes women psychological harm.
-
Research Examines Options for Those With Early-stage Breast Cancer
Results of a large-scale study indicated that 70% of women with a common type of breast cancer do not experience a benefit from chemotherapy. Data suggest that for women with hormone receptor-positive, human epidermal growth factor receptor 2-negative, axillary lymph node-negative breast cancer, post-surgery combination chemotherapy and hormone therapy treatment provides no additional benefit over hormone therapy on its own.
-
Blood Test for Pregnant Women May Predict Preterm Births
In pilot studies of pregnant women, data indicate that ribonucleic acid-based tests of maternal blood can predict delivery date and risk of early childbirth.
-
Add the IUD to EC Counseling
Results of a new study indicate that many young women don’t know that the IUD can be used for emergency contraception or that it is effective. Researchers report that if young women needed emergency contraception, most indicated they would want to know about IUDs in addition to emergency contraceptive pills.
-
Join the Mission: Increase HPV Vaccinations for Girls and Boys
The 67 National Cancer Institute-designated cancer centers and a host of other cancer organizations now are fully endorsing the goal of eliminating cancers caused by human papillomavirus (HPV) through gender-neutral HPV vaccination and evidence-based cancer screening.
-
With Funding Announcement, Trump Begins Reshaping Title X
Funding announcement to reshape Title X.
-
What’s Your Approach to Abnormal Uterine Bleeding?
Statistics indicate that one-third of outpatient gynecologist visits are for abnormal uterine bleeding, with the condition accounting for more than 70% of gynecologic consultations in the perimenopausal and postmenopausal years.
-
Research Examines Self-administered DMPA
New research indicates that use of subcutaneous depot medroxyprogesterone (DMPA-SC, marketed as Sayana Press, Pfizer Inc.) may help women to continue using injectable contraception longer than women who receive traditional intramuscular injections.
-
Push Is on to Combat Drug-resistant Gonorrhea
In a recently released study, Centers for Disease Control and Prevention (CDC) researchers report that while 81% of patients diagnosed with gonorrhea were treated using dual therapy, nearly one in five were treated with a different regimen.
-
FDA Issues Restrictions for Sterilization Option
The Food and Drug Administration has issued new restrictions regarding the sale and distribution of the permanent contraceptive device, Essure.